Gielsdorf W, Herper M
Z Rechtsmed. 1981;87(4):297-303. doi: 10.1007/BF00200645.
After oral ingestion of 400 mg Mefexamidehydrochloride for Mefexamide (I) and its main degradation product Desmethyl-Mefexamide (II) the following pharmakokinetic parameters have been determined: 1. Elimination of I and II follows 1st order kinetics. 2. Biological half-life t 1/2 for I is 4-6, for II 4.5-6.5 H. 3. Elimination rate constant for I and II is between 0.10 to 0.20 h-1. 4. 5-10% of the administered drug are excreted unchanged, 10-16% as Desmethyl-Mefexamide within 72 h after ingestion. 5. The described thinlayer chromatographic and gas chromatographic/mass spectrometric methods allow detection of I and II for at least 72 h after application. 6. II is excreted free and conjugated in nearly equal amounts.
口服400毫克盐酸美非沙胺(用于美非沙胺(I)及其主要降解产物去甲基美非沙胺(II))后,已测定以下药代动力学参数:1. I和II的消除遵循一级动力学。2. I的生物半衰期t 1/2为4 - 6小时,II为4.5 - 6.5小时。3. I和II的消除速率常数在0.10至0.20 h-1之间。4. 给药药物的5 - 10%以原形排泄,10 - 16%在摄入后72小时内以去甲基美非沙胺形式排泄。5. 所述的薄层色谱和气相色谱/质谱方法可在应用后至少72小时检测到I和II。6. II以游离和结合形式排泄的量几乎相等。